Gene · 4085
Papers3,516
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,516
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interplay of kinetochores and catalysts drives rapid assembly of the mitotic checkpoint complex. | Nat Commun | 2025 | 40410156 | PubTator, text mining | PubMed |
| Integrative bioinformatic analysis identifies differentially expressed gene targets as potential biomarkers for anaplastic thyroid cancer. | J Egypt Natl Canc Inst | 2025 | 40350533 | PubTator, text mining | PubMed |
| Thyroid hormone receptor interacting protein 13 is associated with prognosis and immunotherapy efficacy in human cancers: a pan-cancer analysis. | Discov Oncol | 2025 | 40253660 | PubTator, text mining | PubMed |
| p31Comet Splice Variants Induce Distinct Spindle Assembly Checkpoint Dynamics due to Their Unique N-Termini. | Int J Mol Sci | 2025 | 40243841 | PubTator, text mining | PubMed |
| MAD2L1-mediated NANOG nuclear translocation: A critical factor in lung cancer chemoresistance. | Cell Signal | 2025 | 40233918 | PubTator, text mining | PubMed |
| Identification of MAD2L1 as a novel biomarker for hepatoblastoma through bioinformatics and machine learning approaches. | Front Oncol | 2025 | 40231267 | PubTator, text mining | PubMed |
| FDA-approved Levophed as an alternative multitargeted therapeutic against cervical cancer transferase, cell cycle, and regulatory proteins. | Comput Biol Med | 2025 | 40209578 | PubTator, text mining | PubMed |
| Tissue Biomarkers for Predicting the Risk of Oral Cancer in Patients Diagnosed With Oral Leukoplakia: A Systematic Review of the Past 4 Years. | J Oral Pathol Med | 2025 | 40200649 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma. | Cell Death Dis | 2025 | 40180891 | PubTator, text mining | PubMed |
| Molecular mechanism of Mad2 conformational conversion promoted by the Mad2-interaction motif of Cdc20. | Protein Sci | 2025 | 40143766 | PubTator, text mining | PubMed |
| REV7 functions with REV3 as a checkpoint protein delaying mitotic entry until DNA replication is completed. | Cell Rep | 2025 | 40106439 | PubTator, text mining | PubMed |
| Utility of a Large Series of B-Cell Precursor Acute Lymphoblastic Leukemia Cell Lines as a Model System. | Cancer Med | 2025 | 40022573 | PubTator, text mining | PubMed |
| Single-cell analysis of neoplastic plasma cells identifies myeloma pathobiology mediators and potential targets. | Cell Rep Med | 2025 | 39855192 | PubTator, text mining | PubMed |
| The miRNA-mRNA Regulatory Network in Human Hepatocellular Carcinoma by Transcriptomic Analysis From GEO. | Cancer Rep (Hoboken) | 2025 | 39764737 | PubTator, text mining | PubMed |
| Identification of circRNA-miRNA-mRNA networks to explore underlying mechanism in lung cancer. | Health Inf Sci Syst | 2025 | 39676897 | PubTator, text mining | PubMed |
| FRET-FLIM for the Study of Protein-Protein Interactions Underpinning Mitosis Checkpoints. | Methods Mol Biol | 2025 | 39614049 | PubTator, text mining | PubMed |
| MAD2L1 supports MYC-driven liver carcinogenesis in mice and predicts poor prognosis in human hepatocarcinoma. | Toxicol Sci | 2025 | 39316419 | PubTator, text mining | PubMed |
| Identification of MAD2L1 and BUB1B as Potential Biomarkers Associated with Progression and Prognosis of Ovarian Cancer. | Biochem Genet | 2025 | 38683465 | PubTator, text mining | PubMed |
| Transient excited states of the metamorphic protein Mad2 and their implications for function. | Proteins | 2025 | 38221646 | PubTator, text mining | PubMed |
| Unveiling DENND2D as a Novel Prognostic Biomarker for Prostate Cancer Recurrence: From Gene to Prognosis. | Biomedicines | 2024 | 39857609 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4085/papers?page=5